Phio Pharmaceuticals
(NASDAQ) PHIO
Phio Pharmaceuticals Financials at a Glance
Market Cap
$11.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$10.93M
EPS (TTM)
-$1.44
P/E Ratio
-0.70
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$1.00
Volume
148,797.078
Open
$0.99
Price
$1.00
Volume
148,797.078
Open
$0.99
Previous Close
$0.99
Daily Range
$0.99 - $1.03
52-Week Range
$0.81 - $4.19
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$1.00
Volume
148,797.078
Open
$0.99
Previous Close
$0.99
Daily Range
$0.99 - $1.03
52-Week Range
$0.81 - $4.19
Estimated Earnings Date
Aug 13, 2026
PHIO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Phio Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Robert J. Bitterman, Sr., MBA
Website
www.phiopharma.comHeadquarters
Marlborough, PA 19406, US
PHIO Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-77.34%
Return on Capital
-45.76%
Return on Assets
-62.78%
Earnings Yield
-1.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
11.62M
Volume
148.80K
Avg. Volume
158.55K
Financials (TTM)
Gross Profit
-$1.08M
Operating Income
-$11.52M
EBITDA
-$10.93M
Operating Cash Flow
-$10.71M
Capital Expenditure
-$10.00K
Free Cash Flow
-$10.72M
Cash & ST Invst.
$17.03M
Total Debt
$0.00
Phio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$1.00K
+93.3%
Gross Margin
0.00%
N/A
Market Cap
$11.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.94M
N/A
Employees
6
N/A
Net Income
-$4.00M
-126.3%
EBITDA
-$4.00M
-126.2%
Quarterly Fundamentals
Total Cash
$17.03M
+28.3%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-62.78%
N/A
Return on Invested Capital
-67.14%
N/A
Free Cash Flow
-$4.00M
-213.5%
Operating Cash Flow
-$4.00M
-214.0%